FDA Class III drug recalls

25 indexed U.S. FDA drug recall records carry the Class III classification, filed by 19 recalling firms across 20 FDA enforcement events, 4 of which cover more than one recall number, with report dates from 2026-04-29 to 2026-08-12. The median gap between a firm initiating one of these recalls and the FDA publishing it is 26 days. 23 of them (92%) print at least one NDC in the product description and 25 (100%) state a strength. Class III is the least serious tier and is typically applied to recalls of a more administrative character. Every record below links to its own page and on to the verifiable openFDA source. This is a regulatory finding aid, not medical advice.

What this tier looks like in the indexed data

Records in tier 25 of the indexed recall records
Recalling firms 19
FDA events 20 (4 covering >1 recall number)
Report date range 2026-04-29 → 2026-08-12
Median report lag 26 days from initiation to report
Lifecycle statuses 25 Ongoing
Country of record United States (25)
Product forms Tablets (8) · Injection (6) · Capsules (5) · Oral Solution (1) · Extended-Release Capsules (1) · Transdermal System (1) · Ophthalmic Suspension (1) · Gel (1)
Marketing category Rx only (22)
With an NDC in the description 23 (92%)
With a strength in the description 25 (100%)

Firms with Class III records

The 19 firms named on these records, most records first. Each links to the firm's regulatory profile, which aggregates its recall and shortage records across the indexed datasets. Counts are coverage-limited activity signals over the ingested window, never quality ratings.

Recalling firmClass III records
Ascend Laboratories, LLC5
Amerisource Health Services LLC2
Golden State Medical Supply Inc.2
Abbvie Inc.1
American Regent, Inc.1
Amneal Pharmaceuticals, LLC1
Ani Pharmaceuticals, Inc.1
Asclemed Usa Inc.1
Aveva Drug Delivery Systems, Inc.1
Central Admixture Pharmacy Services Inc1
Eugia US LLC1
Fresenius Kabi Usa, LLC1

Enforcement events covering more than one Class III recall number

The FDA files one event ID per enforcement action and one recall number per recalled product configuration, so a single action can appear as several records. These are the 4 multi-record events in this tier.

Event IDRecall numbersRecords
994213D-0737-2026 · D-0738-2026 · D-0739-2026
988562D-0534-2026 · D-0535-2026
988842D-0536-2026 · D-0537-2026
993302D-0735-2026 · D-0736-2026

Products named in more than one Class III record

Matched on the product-name prefix of the FDA's own product description, so different strengths and packages of the same product group together.

ProductRecords in this tierRecall pages
Primidone6D-0585-2026 · D-0533-2026 · D-0534-2026 · D-0535-2026 · D-0536-2026 · D-0537-2026
Dabigatran Etexilate5D-0737-2026 · D-0738-2026 · D-0739-2026 · D-0735-2026 · D-0736-2026

When these recalls were reported

Report-date months across the 25 records in this tier. The report date is when the FDA published the enforcement report, which is normally later than the date the firm began the recall.

Report monthClass III records
2026-084
2026-075
2026-066
2026-059
2026-041

All Class III records (25)

Newest first by report date. Each row links to the record page, which carries the regulatory snapshot, the FDA's verbatim reason field, the identifiers extracted from the product description, and the other records that share its event, firm or product.

RecordTypeDate
Total Parental Nutrition - Pediatric PN Patient-Specific TPN BagCentral Admixture Pharmacy Services Inc2026-08-12
Dabigatran Etexilate CapsulesAscend Laboratories, LLC2026-08-05
Dabigatran Etexilate CapsulesAscend Laboratories, LLC2026-08-05
Dabigatran Etexilate CapsulesAscend Laboratories, LLC2026-08-05
Dabigatran etexilate CapsulesAscend Laboratories, LLC2026-07-29
Lidolog KitAsclemed Usa Inc.2026-07-29
Dabigatran etexilate CapsulesAscend Laboratories, LLC2026-07-29
Fexofenadine Hydrochloride TabletsSun Pharmaceutical Industries Inc2026-07-08
hydrOXYzine Hydrochloride Oral SolutionAni Pharmaceuticals, Inc.2026-07-01
Focalin XR (dexmethylphenidate HCl) 5 mgSandoz Inc2026-06-24
Epinephrine InjectionFresenius Kabi Usa, LLC2026-06-17
Primidone TabletsAmneal Pharmaceuticals, LLC2026-06-17
Lidocaine HCl InjectionEugia US LLC2026-06-10
Nicotine Transdermal System PatchAveva Drug Delivery Systems, Inc.2026-06-03
PRED MILDAbbvie Inc.2026-06-03
Primidone TabletsAmerisource Health Services LLC2026-05-27
Primidone TabletsGolden State Medical Supply Inc.2026-05-27
Primidone TabletsGolden State Medical Supply Inc.2026-05-27
Primidone TabletsAmerisource Health Services LLC2026-05-27
Busulfan InjectionSagent Pharmaceuticals2026-05-27
Primidone Tablets USPLannett Company Inc.2026-05-27
busPIRone Hydrochloride TabletsUnichem Pharmaceuticals Usa Inc.2026-05-13
Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%)Water-jel Technologies, LLC2026-05-06
Levocarnitine InjectionAmerican Regent, Inc.2026-05-06
PremierPremier Dental Products Co2026-04-29

Other recall views

Class I recalls, Class II recalls, or the recall hub for the namespace-level counts, the enforcement-event index and the firm index. Field definitions are in the regulatory intelligence glossary; the data lineage is in the methodology and FDA data sources pages.

Source & provenance

Official source
https://open.fda.gov/apis/drug/enforcement/
Source dataset
openFDA Drug Enforcement API
Publication date
Not available
Ingested
2026-08-22

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.